
A weekly publication by the Bureau of Epidemiology
May 11, 2001
"The reason for collecting, analyzing and disseminating information on a disease is to control that disease. Collection and analysis should not be allowed to consume resources if action does not follow."
--Foege WH et al. Int. J of Epidemiology 1976; 5:29-37.
Richard S. Hopkins, MD, MSPH, Bureau Chief, State Epidemiologist
Don Ward, Surveillance Section Administrator, Epi Update Managing Editor
Jason Glisson, BS, Epi Editorial Assistant
Bureau of Epidemiology Frequent Contributors:
|
Steven Wiersma, MD, MPH, Deputy State Epidemiologist |
Jodi Baldy, MPH, Biological Scientist IV |
|
Ursula E. Bauer, PhD, Chronic Disease Epidemiologist |
Lisa Conti, DVM, MPH, State Public Health Veterinarian |
Regional Epidemiologists:
|
Dolly Katz, PhD, MPH, SE Florida |
Roger Sanderson, RN, MA, SW Florida |
Carina Blackmore, MS Vet. Med., PhD, NE Florida Carina Blackmore, MS Vet. Med., PhD, |
Zuber Mulla, MSPH, Central Florida Carina Blackmore, MS Vet. Med., PhD, |
Please print out this material and share with epidemiology staff, county health department directors, administrators, medical directors, nursing directors, environmental health directors and others with an interest in information of this type. Thank you.
The Bureau of Epidemiology is available 24 hours a day, 7 days a week for consultation at our main number (SunCom 205-4401 or 850/245-4401) PLEASE NOTE: Consultation after 5 p.m. & on weekends is intended for emergencies.
The Department of Health has a home on the World Wide Web at
http://www.doh.state.fl.usIn this issue:
1. The Florida Department of Health Tampa Branch Laboratory
is Moving2. The FDA Commissioner’s Special Citation Team Award
3. Open Job Opportunity Announcement
Grand Rounds for Tuesday May 29, 2001 Weekly Disease Table
1. The Florida Department of Health Tampa Branch Laboratory
is MovingAs of May 25, 2001 our new address and phone numbers are
Florida Department of Health
Bureau of Laboratories – Tampa
3602 Spectrum Blvd., Tampa, FL 33612
(813) 974-8000 or Suncom 574-8000
Fax: (813) 974-5776

Directions from I-275
East on Fowler Ave. to Spectrum Blvd. (first traffic light after Bruce B. Downs Blvd.) Left at Spectrum Blvd. to 3602.
Directions from I-75
West on Fowler Ave. to Spectrum Blvd. Right at Spectrum Blvd. to 3602.
Please contact Dr. Lillian Stark (813/974-5990) or Dr. Deno Kazanis (813/974-8072) if there are any questions.
2. The FDA Commissioner’s Special Citation Team Award
On Friday, May 4, Roberta M. Hammond, Ph.D., accepted the FDA Commissioner’s Special Citation team award from FDA on behalf of the Outbreak Coordination Workgroup. The award was presented by Bernard A. Schwetz, D.V.M., Ph.D., Acting Principal Deputy Commissioner and Dennis E. Baker, Associate Commissioner for Regulatory Affairs in Rockville, MD. RADM Kenneth P. Moritsugu, Deputy Surgeon General, was also present. The Outbreak Coordination Workgroup is one of six workgroups that began a little over two years ago as part of the FDA-sponsored National Food Safety System (NFSS) effort to build local-state-federal partnerships in food safety. The award states: "For exceptional performance in enhancing food safety through a local-state-federal workgroup to improve coordination, cooperation and communication regarding multi-state foodborne outbreak investigations."
The Outbreak Coordination Workgroup has recently completed work on a web-based document: Multi-State Foodborne Outbreak Investigations: Guidelines for Improving Coordination and Communication. Included are outbreak information gathering guidelines, audio conference etiquette, important contacts and phone numbers, descriptions of the multi-state investigation process and more. The intent of the document is to help enhance communication and coordination during the active phases of a multi-state foodborne outbreak investigation. This document has recently been posted to FDA's Division of Federal-State Relations website at:
http://www.fda.gov/ora/fed_state/NFSS/Default.htm .Outbreak Coordination Workgroup Team members include:
|
Roberta M. Hammond, Ph.D. Co-chair |
Florida Department of Health |
|
Michael P. Tormey, M.P.H. Co-chair |
Los Angeles County Department of Health Services |
|
Frank L. Davido |
Environmental Protection Agency |
|
Jeff Farrar, D.V.M, Ph.D. 1999 co-chair |
California Department of Health Services |
|
Anthony Fiore, M.D. |
Centers for Disease Control and Prevention |
|
James J. Gibson, M.D., M.P.H. 1999 co-chair |
South Carolina Department of Health |
|
John J. Guzewich, R.S., M.P.H. |
Food and Drug Administration (Center for Food Safety and Nutrition) |
|
John Kobayashi, M.D., M.P.H. |
Washington State Department of Health |
|
Priscilla Levine |
US Department of Agriculture |
|
Ellen Morrison |
Food and Drug Administration (Office of Regulatory Affairs) |
|
Nelson P. Moyer, Ph.D. |
University of Iowa Hygienic Laboratory |
|
Louise Ogden |
Minnesota Department of Agriculture |
|
Sarah C. Pichette, M.P.H. |
Food and Drug Administration (Office of Regulatory Affairs) |
|
Jerry Rowland |
Metro Health Department, Nashville, Tennessee |
|
John P. Sanders, Jr., D.V.M. |
Food and Drug Administration (Center for Food Safety and Nutrition) |
|
Debra A. Street, Ph.D. |
Food and Drug Administration (Center for Food Safety and Nutrition) |
|
Thomas J. van Gilder, M.D., M.P.H. |
Centers for Disease Control and Prevention |
3. Open job opportunity announcement: Advanced Registered Nurse Practitioner Specialist, Bureau of STD Prevention and Control, Department of Health, Tallahassee, Florida
This is a statewide Florida ARNP Specialist career service position providing STD primary care at a county public health department clinic (20% of time) and planning, coordinating, and implementing STD program policy and protocols and performing technical assistance and quality improvement activities 80% of the time. The position is located in scenic Tallahassee, Florida, in the Bureau of STD.
EXAMPLES OF WORK PERFORMEDProvides consultation and technical assistance in evaluating the appropriateness of client care as it relates to STD services.
Serves as a resource person for technical knowledge in the field of STD services.
Provides leadership in the development and design of STD health educational materials and training of personnel.
Assists in the development of STD policies, guidelines and protocols related to the management of STD nursing care problems and the delivery of client care by nurses and clinicians.
Assesses the overall delivery of care in the STD setting and designs, implements and monitors corrective action plans.
Acts as STD clinical liaison between state and local health agencies, interpreting state policies, advising as to program changes, and clarifying clinical needs on the local level to program directors and administrators on the state level.
Participates in the development of research in the field of STD.
Monitors the delivery of STD health services by physicians, nurse practitioners, and nurses, and evaluates professional methods and techniques.
Performs complete physical appraisal of clients appropriate to background, training, and client need.
Compiles and evaluates medical histories and physical findings.
Initiates diagnostic laboratory tests and interprets and evaluates laboratory results.
Monitors medication and initiates appropriate therapies for certain conditions and alters medications according to variations in a client's response within established protocols.
Instructs advanced registered nurse practitioners in skills and abilities needed to upgrade their competencies.
Performs related work as required.
KNOWLEDGE, SKILLS AND ABILITIES
Knowledge of the principles and practices of program management and delivery of health services.
Knowledge of nursing principles, practices and techniques.
Knowledge of human anatomy and physiology.
Knowledge of STD services helpful.
Ability to plan, organize and coordinate work assignments.
Ability to apply the consultative process in problem-solving activities.
Ability to collect, interpret and analyze statistical, demographic and service data.
Ability to formulate and monitor nursing standards and operating policies and procedures.
Ability to develop and implement various program monitoring methodologies and techniques.
Ability to communicate effectively.
Ability to establish and maintain effective working relationships with others.
Ability to perform compete physical appraisals of clients.
Ability to manage the care of clients.
Ability to initiate diagnostic laboratory tests and evaluate the results.
Ability to administer prescribed medications.
Ability to compile and evaluate medical histories and other clinical and laboratory data.
MINIMUM QUALIFICATIONS
Certification as an Advanced Registered Nurse Practitioner (ARNP) in accordance with Florida Statute 464, a bachelor's degree from an accredited college or university with a major in nursing and four years of professional nursing experience, two years of which must have been in a ARNP capacity.
A master's degree from an accredited college or university in nursing can substitute for two years of the required general professional nursing experience.
NOTE
Preference will be given to applicants with experience working in STD clinics.
A State of Florida job application will need to be completed and mailed or FAXED.
http://www.myflorida.com/dms/hrm/jobsdirect/app.pdf is the state of FL job application form.
Pay grade 78; Annual Salary Range:
$38,459.72 to $71,547.32Contact:
TAMMY ARNOLD
BUREAU OF STD
DEPT OF HEALTH
4052 BALD CYPRESS WAY BIN A19
TALLAHASSEE, FL. 32399-1716
Phone:
4. Grand Rounds for Tuesday May 29, 2001
"Surveillance for West Nile (WN) Virus"
Lisa Conti, DVM, MPH State Public Health Veterinarian, Bureau of Epidemiology, Florida Department of Health, and Robin Oliveri Arbovirus Surveillance Coordinator, Bureau of Epidemiology
11:00 AM – 12:00 PM EST
Dial-in by 11:10 AM at (850) 487-8587 or SunCom 277-8587
Abstract
Florida is conducting WN virus surveillance in addition to St. Louis encephalitis and eastern equine encephalitis monitoring activities. During its brief history, WN has manifested itself in the United States with bird die-offs, especially American crows. Thus, tracking bird mortality in Florida is considered a useful tool for WNV detection and surveillance. WN has also caused morbidity and mortality among people and other animals, and has been identified in a number of vector species. No human or animal cases have been reported in Florida. The state's interagency effort includes looking for evidence of WN virus in wild birds, sentinel chickens, horses and people and a protocol for mosquito surveillance when WN virus is detected in Florida.
Additional Information
Further details regarding the audio-conference call and PowerPoint files will be posted on the Bureau of Epidemiology Intranet web site. Be sure and register online for nursing CEU's and contact hours for environmental health professionals. We will also be providing CEU's for Veterinary Medicine. Information about up-coming topics and presenters will also be posted in the Epi Update. If either of these access points is unavailable to you, please e-mail Melanie Black [Melanie_Black@doh.state.fl] or telephone (850) 245-4444 ext. 2448 (SunCom 205-4444 ext. 2448) to request presentation materials.
Important
While we realize you might not always be able to call in at 11:00 AM, it can be distracting to the speaker and others in the audience when participants dial-in throughout the hour. Please try to call in on time and remember to put your phones on mute so as not to disturb others. Thank you for your cooperation.
5. Weekly Disease Table (Week 18)
| DISEASE |
1999 TO |
2000 TO |
3-YEAR |
2000 |
2001 TO |
2001 |
|
Animal Rabies |
59 |
45 |
60.3 |
161 |
85 |
10 |
|
Anthrax |
0 |
0 |
0 |
0 |
0 |
0 |
|
Botulism, foodborne |
0 |
0 |
0 |
0 |
0 |
0 |
|
Botulism, infant |
0 |
0 |
0 |
0 |
0 |
0 |
|
Botulism, wound |
0 |
0 |
0 |
0 |
0 |
0 |
|
Botulism, other |
0 |
0 |
0 |
0 |
0 |
0 |
|
Brucellosis |
0 |
1 |
0.7 |
2 |
1 |
0 |
|
Campylobacteriosis |
242 |
248 |
230.7 |
1026 |
217 |
15 |
|
Ciguatera |
1 |
0 |
0.3 |
14 |
0 |
0 |
|
Cryptosporidiosis |
28 |
14 |
23.3 |
180 |
22 |
1 |
|
Cyclosporiasis |
0 |
1 |
1 |
9 |
22 |
0 |
|
Dengue Fever |
1 |
0 |
0.7 |
3 |
2 |
0 |
|
Diphtheria |
0 |
0 |
0 |
0 |
0 |
0 |
|
Ehrlichiosis, human |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, chickenpox |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, Eastern Equine |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, herpes |
2 |
2 |
2.3 |
7 |
0 |
0 |
|
Encephalitis, influenza |
0 |
1 |
0.3 |
1 |
0 |
0 |
|
Encephalitis, measles |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, mumps |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, other |
2 |
1 |
1.3 |
8 |
1 |
0 |
|
Encephalitis, St. Louis |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, Venezuelan |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, Western Equine |
0 |
0 |
0 |
0 |
0 |
0 |
|
Escherichia Coli 0157:H7 |
11 |
12 |
9 |
95 |
6 |
0 |
|
Escherichia Coli, other |
7 |
3 |
4 |
13 |
2 |
0 |
|
Giardiasis |
259 |
288 |
292.3 |
1466 |
248 |
24 |
|
H. Influenzae Cellulitis |
0 |
0 |
0.7 |
1 |
0 |
0 |
|
H. Influenzae Epiglottitis |
0 |
0 |
0 |
1 |
0 |
0 |
|
H. Influenzae Meningitis |
7 |
1 |
4.3 |
11 |
3 |
0 |
|
H. Influenzae Pneumonia |
2 |
2 |
2.3 |
7 |
11 |
0 |
|
H. Influenzae Prim.Bacteremia |
7 |
14 |
9 |
57 |
33 |
3 |
|
H. Influenzae Septic Arthritis |
0 |
0 |
0 |
1 |
0 |
0 |
|
Hantaviris Infection |
0 |
0 |
0 |
0 |
0 |
0 |
|
Hemolytic Uremic Syndrome |
1 |
4 |
1.7 |
17 |
1 |
0 |
|
Hemorrhagic Fever |
0 |
0 |
0 |
0 |
0 |
0 |
|
Hepatitis A |
203 |
164 |
184.7 |
589 |
172 |
11 |
|
Hepatitis B |
110 |
109 |
108 |
526 |
118 |
11 |
|
Hepatitis B (+HbsAg in pregnant women) |
5 |
99 |
34.7 |
492 |
84 |
10 |
|
Hepatitis, Perinatal Hep B |
0 |
0 |
0 |
1 |
2 |
0 |
|
Hepatitis C |
13 |
5 |
6 |
19 |
4 |
0 |
|
Hepatitis, Non-A, Non-B |
0 |
3 |
8.3 |
6 |
1 |
0 |
|
Hepatitis, Other, including unspecified |
6 |
4 |
3.7 |
7 |
3 |
0 |
|
Lead Poisoning |
495 |
368 |
453 |
1219 |
184 |
11 |
|
Legionellosis |
7 |
13 |
11.3 |
51 |
11 |
2 |
|
Leprosy |
0 |
0 |
1 |
4 |
0 |
0 |
|
Leptospirosis |
0 |
0 |
0 |
2 |
0 |
0 |
|
Listeriosis |
5 |
9 |
4.7 |
32 |
7 |
0 |
|
Lyme Disease |
3 |
6 |
6 |
54 |
2 |
1 |
|
Malaria |
25 |
19 |
20.7 |
90 |
15 |
1 |
|
Measles |
1 |
0 |
0.7 |
2 |
0 |
0 |
|
Meningitis, Group B Strep |
5 |
5 |
5.3 |
21 |
4 |
0 |
|
Meningitis, List Monocytogenes |
2 |
1 |
2 |
7 |
0 |
0 |
|
Meningitis, Meningococcal |
17 |
12 |
14.3 |
41 |
30 |
1 |
|
Meningitis, other |
17 |
30 |
21.3 |
110 |
20 |
1 |
|
Meningitis, Strep Pneumoniae |
49 |
45 |
45.7 |
112 |
24 |
0 |
|
Meningococcemia, disseminated |
25 |
28 |
28.3 |
80 |
24 |
5 |
|
Mercury Poisoning |
1 |
3 |
1.3 |
11 |
1 |
1 |
|
Mumps |
1 |
1 |
3.3 |
4 |
0 |
0 |
|
Neurotoxic Shellfish Poisoning |
0 |
0 |
0 |
0 |
0 |
0 |
|
Pertussis |
9 |
13 |
11 |
48 |
5 |
0 |
|
Plague, Bubonic |
0 |
0 |
0 |
0 |
0 |
0 |
|
Plague, Pneumonic |
0 |
0 |
0 |
0 |
0 |
0 |
|
Poliomyelitis |
0 |
0 |
0 |
0 |
0 |
0 |
|
Psittacosis |
0 |
0 |
0 |
3 |
0 |
0 |
|
Q Fever |
0 |
0 |
0 |
0 |
0 |
0 |
|
Human Rabies |
0 |
0 |
0 |
0 |
0 |
0 |
|
Rocky Mountain Spotted Fever |
1 |
0 |
0.7 |
1 |
1 |
0 |
|
Rubella |
0 |
1 |
0.7 |
2 |
1 |
1 |
|
Rubella, Congenital |
0 |
0 |
0 |
1 |
0 |
0 |
|
Salmonellosis |
502 |
448 |
464.7 |
2756 |
486 |
33 |
|
Shigellosis |
434 |
386 |
419.3 |
1292 |
193 |
14 |
|
Smallpox |
0 |
0 |
0 |
0 |
0 |
0 |
|
Staphylococcus Aureus (GISA/VISA) |
0 |
0 |
0 |
0 |
0 |
0 |
|
Staphylococcus Aureus (GRSA/VRSA) |
0 |
0 |
0 |
0 |
0 |
0 |
|
Streptococcal Disease, Invasive Group A |
17 |
51 |
30.3 |
147 |
60 |
2 |
|
Streptococcus Pneumoniae, Invasive |
198 |
370 |
252.7 |
1150 |
399 |
17 |
|
Tetanus |
1 |
0 |
0.7 |
1 |
2 |
0 |
|
Toxoplasmosis |
4 |
2 |
3.3 |
12 |
4 |
1 |
|
Trichinosis |
0 |
0 |
0 |
1 |
0 |
0 |
|
Tularemia |
0 |
0 |
0 |
0 |
0 |
0 |
|
Typhoid Fever |
19 |
1 |
9 |
12 |
3 |
1 |
|
Vibrio Alginolyticus |
3 |
2 |
2 |
15 |
1 |
1 |
|
Vibrio Cholerae Type 01 |
0 |
0 |
0 |
0 |
0 |
0 |
|
Vibrio Cholerae Non-01 |
3 |
3 |
2.3 |
4 |
0 |
0 |
|
Vibrio Fluvialis |
1 |
0 |
0.3 |
2 |
0 |
0 |
|
Vibrio Hollisae |
3 |
3 |
2.7 |
3 |
0 |
0 |
|
Vibrio Mimicus |
1 |
1 |
0.7 |
2 |
0 |
0 |
|
Vibrio, other |
1 |
0 |
0.3 |
2 |
0 |
0 |
|
Vibrio Parahaemolyticus |
2 |
1 |
1.7 |
16 |
0 |
0 |
|
Vibrio Vulnificus |
2 |
0 |
1.3 |
13 |
2 |
2 |
|
Yellow Fever |
0 |
0 |
0 |
0 |
0 |
0 |